According to a release, Stryker reported net sales of $5 Billion in the second half of 2023. This was $503 Million, or 11.2% more than the second half of 2022.
Organic net sales grew 11.9%. 11.4% was from increased unit volume, and 0.5% due to higher prices. MedSurg sales accounted $2.9 billion, while orthopedics and spine sales amounted to $2.1 billion.
The company’s net earnings for the quarter were $738.9 million, with a net earnings per share diluted of $1.93. These figures represent an increase of 12.5% and 12.2%, respectively.
“We delivered
